Citius Oncology Inc
NASDAQ:CTOR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Citius Oncology Inc
NASDAQ:CTOR
|
US |
|
DCM Ltd
NSE:DCM
|
IN |
|
Indus Holding AG
XETRA:INH
|
DE |
|
R
|
Rav Bariach 08 Industries Ltd
TASE:BRIH
|
IL |
|
U. P. Hotels Ltd
BSE:509960
|
IN |
|
G
|
Global Environmental Energy Corp
OTC:GEECF
|
BS |
|
Fabled Silver Gold Corp
XTSX:FCO
|
CA |
|
H
|
Hangzhou Sf Intra-City Industrial Co Ltd
HKEX:9699
|
CN |
|
G
|
Great Republic Mining Corp
CNSX:GRM
|
CA |
|
Shenzhen Zqgame Co Ltd
SZSE:300052
|
CN |
|
Retail Opportunity Investments Corp
NASDAQ:ROIC
|
US |
Income Statement
Earnings Waterfall
Citius Oncology Inc
Income Statement
Citius Oncology Inc
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
|
| Gross Profit | ||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
(1)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
|
| Operating Income | ||||||
| Operating Expenses |
(31)
|
(34)
|
(39)
|
(24)
|
(26)
|
|
| Selling, General & Administrative |
(24)
|
(25)
|
(28)
|
(17)
|
(19)
|
|
| Research & Development |
(6)
|
(9)
|
(10)
|
(6)
|
(6)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
(1)
|
|
| Operating Income |
(31)
N/A
|
(34)
-9%
|
(39)
-13%
|
(24)
+39%
|
(22)
+5%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(32)
N/A
|
(35)
-9%
|
(40)
-15%
|
(24)
+41%
|
(23)
+5%
|
|
| Net Income | ||||||
| Tax Provision |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Income from Continuing Operations |
(33)
|
(36)
|
(42)
|
(25)
|
(24)
|
|
| Net Income (Common) |
(33)
N/A
|
(36)
-9%
|
(42)
-16%
|
(25)
+41%
|
(24)
+5%
|
|
| EPS (Diluted) |
-0.45
N/A
|
-0.5
-11%
|
-0.6
-20%
|
-0.34
+43%
|
-0.27
+21%
|
|